The carnitine-acylcarnitine translocase (CACT) is a mitochondrial membrane protein that shuttles long chain fatty acids between the cytosol and intramitochondrial matrix. This enzyme catalyzes the conversion of acylcarnitine to acyl CoA for fatty acid oxidation. CACT deficiency is a life-threatening, autosomal recessive disorder, which manifests in early infancy with hypoketotic hypoglycemia, cardiomyopathy, liver failure, and muscle weakness. The disease is usually lethal. Only about 20% of the reported cases have mild phenotype compatible with long-term survival. Mutations in SLC25A20 gene are responsible for the disease. The human SLC25A20 gene is mapped to chromosome 3p21. It contains 9 coding exons and encodes a protein of 301 amino acids. To date, 15 private mutations have been reported. Reasons for Referral:
Testing Methodology:The exons and flanking intronic regions of the SLC25A20 gene are PCR amplified and sequenced in both the forward and reverse directions. Specimen Requirements:
Blood: EDTA (purple-top) tubes: Adult: 3 cc; Child and Infant: 3
cc Turnaround Time:Index: 2-4 weeks CPT Codes and Prices:
Index: 83891, 83904x18, 83898x9, 83912,
83894x2 Shipping InformationForms:>> Gene Sequencing Requisition References:
Test Codes:Index: 3435 |